AZN-阿斯利康股票行情，NASDAQ: AZN股票价格，图表，新闻

行情

AZN

阿斯利康

NASDAQ

实时行情|Nasdaq Last Sale

56.60

+0.15

+0.27%

盘后: 56.68 +0.08 +0.14% 19:54 09/16 EDT

开盘

56.47

昨收

56.45

最高

56.73

最低

56.01

成交量

534.47万

成交额

52周最高

60.93

52周最低

46.48

市值

1,753.61亿

市盈率(TTM)

39.51

分时

5日

1月

3月

1年

5年

随着欧盟购买剂量，Novavax 仍有很多上行空间

Investor Place · 5小时前

NetworkNewsAudio Lexaria Bioscience Corp.（纳斯达克股票代码：LEXX）引领高血压治疗创新

(MENAFN - Investor Brand Network) Hypertension, or high blood pressure, is rampant in America. An estimated 45% of adults in the United States, or 108 million people, have hypertension, yet only about one out of every four have their condition under contro...

MENAFN · 6小时前

辉瑞、Moderna 在 FDA 会议前支持 COVID 疫苗助推器

Zacks.com · 11小时前

Direxion 计划推出 mRNA ETF 以专注于 COVID-19疫苗背后的技术

Direxion is planning to launch the Direxion mRNA ETF to offer investors exposure to messenger RNA technology, the cutting-edge research area that served as the basis for most COVID-19 vaccines.

Seekingalpha · 11小时前

更新 1-伊朗批准美国强生公司在与第五波 COVID 浪潮作斗争时采取的措施

Iran’s new government has approved use of U.S. firm Johnson & Johnson's COVID-19 vaccine, a senior official said on Thursday, as the Islamic Republic fights a fifth wave of infections. The announcement came eight months after Supreme Leader Ayatollah Ali ...

Reuters · 11小时前

随着第五波蔓延，伊朗批准美国强生 (J&J) 新型冠状病毒 (J&J) 注射

Iran’s new government has approved the COVID-19 vaccine developed by U.S. firm Johnson & Johnson , a senior official said on Thursday, as the Islamic Republic faces a fifth wave of infections. The announcement came eight months after Supreme Leader Ayatol...

Reuters · 12小时前

更新 1-工业、旅游类股领涨英国股市； Ashtead Group 跳跃

reuters.com · 17小时前

工业、金融类股领涨英国股市； Ashtead Group 跳跃

reuters.com · 18小时前

财务预测

实际值（美元）

预测值（美元）

利润表更多

净利润（美元）

同比（%）

资产负债表更多

总资产（美元）

总负债（美元）

资产负债率（%）

现金流表更多

经营现金流（美元）

同比（%）

了解AZN最新的财务预测，通过AZN每股收益，每股净资产，每股现金流等数据分析阿斯利康近期的经营情况，然后做出明智的投资选择。

分析师评级

6位分析师的综合评级

买入

免责声明：分析师观点仅供投资者决策参考，不构成任何买卖投资建议。

目标价格预测

分析师预测AZN价格均价为68.58，最高价位70.00，最低价为66.00。

EPS

机构持股

总机构数: 1,362

机构持股: 8.99亿

持股比例: 29.00%

总股本: 30.98亿

类型机构数股数

增持

394

9,753.68万

建仓

103

2,302.22万

减持

433

5,151.86万

平仓

103

2,217.67万

业绩
资产分布
分红历史

暂无数据

所属板块

制药

-0.24%

制药与医学研究

+0.11%

高管信息

Non-Executive Chairman/Independent Director

Leif Johansson

Chief Executive Officer/Executive Director

Pascal Soriot

Chief Financial Officer/Executive Director

Aradhana Sarin

Chief Human Resource Officer/General Counsel

Jeffrey Pott

Executive Vice President/Chief Compliance Officer

Katarina Ageborg

Executive Vice President

Jose Baselga

Executive Vice President

Pam Cheng

Executive Vice President

Ruud Dobber

Executive Vice President

David Fredrickson

Executive Vice President

Menelas Pangalos

Executive Vice President

Iskra Reic

Executive Vice President

Leon Wang

Secretary

Adrian Kemp

Non-Executive Director

Euan Ashley

Non-Executive Director

Diana Layfield

Non-Executive Director

Tony Mok

Non-Executive Director

Andreas Rummelt

Non-Executive Director

Marcus Wallenberg